UK And Canada To Allow Travellers Vaccinated With Covaxin

WHO approves Covaxin ,Covaxin For Children, covaxin deal covaxin phase 3 trial, covaxin phase 3 analysis, PIL against Covaxin trial, Fights Indian Strain, Covaxin Phase I Trial Results: Vaccine Induced Antibody And Showed No Serious Side Effects, Covaxin trials for children, covaxin children, UK canada covaxin
UK canada covaxin: Travellers fully vaccinated with Bharat Biotech’s Covaxin can travel to Canada from November 30 onwards. The Canadian government announced, “…three additional Covid-19 vaccines approved for use by the World Health Organisation (WHO) will be accepted for travel to and within Canada.” The other two vaccines are Sinopharm (also referred to as Covilo), Sinovac (also referred to as Coronavac)

Till now, Canada was only allowing the entry of travellers vaccinated with Pfizer-BioNTech, Moderna, AstraZeneca and Johnson and Johnson. It said in a statement that to qualify as a fully vaccinated traveller, you must have received

  • at least two doses of an accepted vaccine
  • or a mix of two accepted vaccines
  • or at least one dose of the Janssen/Johnson and Johnson vaccine

These should be put at least 14 full days prior to the day you travel.

Besides Canada, United Kingdom will also allow Indians vaccinated with Covaxin to travel from November 22 onwards. This means that Indian travellers who have been vaccinated with Covaxin won’t have to self-isolate after arrival in Britain.

According to reports, government officials said that as many as 110 countries gave recognition to Covaxin and Covishield.

The World Health Organization (WHO) granted an emergency use listing to Covaxin early in November. This would mean that the Bharat Biotech’s COVID-19 vaccine made in India would be recognised by other countries as well as India. The individuals who take the vaccine will not need to self-quarantine or face restrictions while travelling abroad. The WHO in a tweet wrote, “WHO has granted emergency use listing (EUL) to COVAXIN (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of COVID-19.” Read more about it here. 

Suggested Reading

Covaxin Gets Emergency Use Approval For Children Aged 2-18: Reports

Covaxin For Kids? Bharat Biotech Says Stage 2/3 Trials Completed

AIIMS, Delhi to start second dose trial of COVAXIN on 2-6 years old children : Reports